Jail-based HCV interventions, especially those offering treatment, significantly enhance HCV elimination in people who inject drugs — and are a cost-effective public health strategy.
Stanford University news release
A Stanford study shows that jail-based hepatitis C programs could cut new infections by nearly half among people who inject drugs.
The study, published in JAMA Internal Medicine, modeled how hepatitis C spreads through networks of people who inject drugs as they move between jails and communities. Results showed that a combination of testing people when they enter jail, starting treatment in jail, and connecting them to care after release could reduce new infections by 47% and deaths by 40% in this population. The approach would cost about $11,000 for each year of healthy life gained, well within the range that public health experts consider good value for money.
Read the full news release here.
Source : Stanford University
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.